-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Repare Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to Q1 2025.
- Repare Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$29.1M, a 344% decline year-over-year.
- Repare Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$76.4M, a 39.9% increase from 2023.
- Repare Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$127M, a 39590% decline from 2022.
- Repare Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $322K.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)